Exelixis
EXEL
#1822
Rank
โ‚น1.075 T
Marketcap
โ‚น4,011
Share price
-0.50%
Change (1 day)
18.52%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: โ‚น1.075 Trillion

As of March 2026 Exelixis has a market cap of โ‚น1.075 Trillion. This makes Exelixis the world's 1822th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น1.075 T-3.77%
2025โ‚น1.117 T34.91%
2024โ‚น828.30 B33.37%
2023โ‚น621.05 B45.06%
2022โ‚น428.13 B-0.55%
2021โ‚น430.49 B-5.46%
2020โ‚น455.37 B19.28%
2019โ‚น381.78 B-7.43%
2018โ‚น412.44 B-28.18%
2017โ‚น574.27 B95.49%
2016โ‚น293.75 B243.81%
2015โ‚น85.44 B377.9%
2014โ‚น17.87 B-74.42%
2013โ‚น69.88 B52.04%
2012โ‚น45.96 B35.37%
2011โ‚น33.95 B-15.54%
2010โ‚น40.20 B8.94%
2009โ‚น36.90 B44.84%
2008โ‚น25.47 B-28.18%
2007โ‚น35.47 B-7.28%
2006โ‚น38.26 B8.22%
2005โ‚น35.35 B14.59%
2004โ‚น30.85 B34.83%
2003โ‚น22.88 B0.45%
2002โ‚น22.78 B-49.4%
2001โ‚น45.02 B41.16%
2000โ‚น31.89 B

End of Day market cap according to different sources

On Feb 28th, 2026 the market cap of Exelixis was reported to be:

โ‚น1.041 Trillion
by Nasdaq info icon info icon
โ‚น1.075 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น54.496 T 4,968.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น14.310 T 1,230.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น19.046 T 1,671.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น10.697 T 894.82%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น28.152 T 2,518.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น11.561 T 975.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น10.800 T 904.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
โ‚น1.42 B-99.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
โ‚น47.46 B-95.59%๐Ÿ‡บ๐Ÿ‡ธ USA